• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

INOCA 的功能和经济影响及冠状动脉微血管功能障碍的影响。

Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction.

机构信息

Division of Cardiovascular Medicine and the Cardiac Imaging Center, University of Virginia Health System, Charlottesville, Virginia, USA.

Division of Cardiovascular Medicine and the Cardiac Imaging Center, University of Virginia Health System, Charlottesville, Virginia, USA; Biomedical Engineering and Imaging Institute and Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

出版信息

JACC Cardiovasc Imaging. 2021 Jul;14(7):1369-1379. doi: 10.1016/j.jcmg.2021.01.041. Epub 2021 Apr 14.

DOI:10.1016/j.jcmg.2021.01.041
PMID:33865784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8273074/
Abstract

OBJECTIVES

This study sought to better characterize the quality of life and economic impact in patients with symptoms of ischemia and no obstructive coronary disease (INOCA) and to identify the influence of coronary microvascular dysfunction (CMD).

BACKGROUND

Patients with INOCA have a high symptom burden and an increased incidence of major adverse cardiac events. CMD is a frequent cause of INOCA. The morbidity associated with INOCA and CMD has not been well-characterized.

METHODS

Sixty-six patients with INOCA underwent stress cardiac magnetic resonance with calculation of myocardial perfusion reserve (MPR); MPR 2.0 to 2.4 was considered borderline-reduced (possible CMD) and MPR <2.0 was defined as reduced (definite CMD). Subjects completed quality of life questionnaires to assess the morbidity and economic impact of INOCA. Questionnaire results were compared between INOCA patients with and without CMD. In addition, logistic regression was used to determine the predictors of CMD within the INOCA population.

RESULTS

The prevalence of definite CMD was 24%. Definite or borderline CMD was present in 59% (MPR ≤2.4). Patients with INOCA reported greater physical limitation, angina frequency, and reduced quality of life compared to referent stable coronary artery disease and acute myocardial infarction populations. In addition, Patients with INOCA reported frequent time missed from work and work limitations, suggesting a substantial economic impact. No difference was observed in reported symptoms between INOCA patients with and without CMD. Glomerular filtration rate and body-mass index were significant predictors of CMD in multivariable regression analysis.

CONCLUSIONS

INOCA is associated with high morbidity similar to other high-risk cardiac populations, and work limitations reported by Patients with INOCA suggest a substantial economic impact. CMD is a common cause of INOCA but is not associated with increased morbidity. These results suggest that there is significant symptom burden in the INOCA population regardless of etiology.

摘要

目的

本研究旨在更好地描述有缺血症状但无阻塞性冠状动脉疾病(INOCA)患者的生活质量和经济影响,并确定冠状动脉微血管功能障碍(CMD)的影响。

背景

有 INOCA 的患者症状负担重,且发生重大不良心脏事件的几率增加。CMD 是 INOCA 的常见病因。INOCA 和 CMD 相关的发病率尚未得到充分描述。

方法

66 例有 INOCA 的患者接受了心脏磁共振负荷试验,计算心肌灌注储备(MPR);MPR 在 2.0 至 2.4 之间被认为是临界降低(可能存在 CMD),MPR<2.0 被定义为降低(明确存在 CMD)。患者完成了生活质量问卷,以评估 INOCA 的发病率和经济影响。比较了有和无 CMD 的 INOCA 患者的问卷结果。此外,还使用逻辑回归确定了 INOCA 人群中 CMD 的预测因素。

结果

明确 CMD 的患病率为 24%。明确或临界 CMD 见于 59%(MPR≤2.4)的患者。与参照的稳定型冠状动脉疾病和急性心肌梗死人群相比,有 INOCA 的患者报告了更大的身体受限、心绞痛发作频率和降低的生活质量。此外,有 INOCA 的患者报告经常缺勤和工作受限,表明经济影响较大。在有和无 CMD 的 INOCA 患者之间,报告的症状没有差异。肾小球滤过率和体重指数是多变量回归分析中 CMD 的显著预测因素。

结论

INOCA 与其他高危心脏人群一样,发病率高,且有 INOCA 的患者报告的工作受限表明经济影响较大。CMD 是 INOCA 的常见病因,但与发病率增加无关。这些结果表明,无论病因如何,INOCA 人群都存在明显的症状负担。

相似文献

1
Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction.INOCA 的功能和经济影响及冠状动脉微血管功能障碍的影响。
JACC Cardiovasc Imaging. 2021 Jul;14(7):1369-1379. doi: 10.1016/j.jcmg.2021.01.041. Epub 2021 Apr 14.
2
Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.根据冠状动脉微血管功能障碍,非阻塞性冠状动脉疾病中的缺血的临床相关性。
J Am Heart Assoc. 2022 May 3;11(9):e025171. doi: 10.1161/JAHA.121.025171. Epub 2022 Apr 27.
3
Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA.在INOCA 中,联合冠状动脉造影衍生的 IMR 和 CZT SPECT 心肌灌注成像的预后价值。
J Nucl Cardiol. 2023 Apr;30(2):684-701. doi: 10.1007/s12350-022-03038-w. Epub 2022 Aug 2.
4
Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.非阻塞性冠状动脉狭窄对INOCA 患者冠状动脉微血管功能障碍及长期结局的影响。
Clin Cardiol. 2023 Feb;46(2):204-213. doi: 10.1002/clc.23962. Epub 2022 Dec 25.
5
Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.左心室圆周应变与冠状动脉微血管功能障碍:来自女性缺血综合征评估冠状动脉血管功能障碍(WISE-CVD)项目的报告。
Int J Cardiol. 2021 Mar 15;327:25-30. doi: 10.1016/j.ijcard.2020.11.006. Epub 2020 Nov 14.
6
"The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".《INOCA-IT:意大利非阻塞性冠状动脉疾病(INOCA)患者缺血多中心注册研究的原理和设计》
Int J Cardiol. 2024 May 1;402:131859. doi: 10.1016/j.ijcard.2024.131859. Epub 2024 Feb 13.
7
Intracoronary electrocardiogram detects coronary microvascular dysfunction and ischemia in patients with no obstructive coronary arteries disease.冠状动脉内心电图可检测无阻塞性冠状动脉疾病患者的冠状动脉微血管功能障碍和缺血情况。
Am Heart J. 2024 Apr;270:62-74. doi: 10.1016/j.ahj.2024.01.003. Epub 2024 Jan 25.
8
Coronary Microvascular Dysfunction.冠状动脉微血管功能障碍
J Clin Med. 2020 Sep 6;9(9):2880. doi: 10.3390/jcm9092880.
9
Ischemia and no obstructive coronary arteries (INOCA): A narrative review.缺血但非阻塞性冠状动脉疾病(INOCA):一篇叙述性综述。
Atherosclerosis. 2022 Dec;363:8-21. doi: 10.1016/j.atherosclerosis.2022.11.009. Epub 2022 Nov 12.
10
FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.游离甲状腺素 4/游离甲状腺素 3 比值:一种新型生物标志物可预测甲状腺功能正常的心绞痛样胸痛患者的冠状动脉微血管功能障碍(CMD)。
Front Endocrinol (Lausanne). 2022 Sep 15;13:1021326. doi: 10.3389/fendo.2022.1021326. eCollection 2022.

引用本文的文献

1
Cardiac Magnetic Resonance Imaging in Heart Failure.心力衰竭中的心脏磁共振成像
Cardiovasc Innov Appl. 2024 Jan 3;9(1). doi: 10.15212/cvia.2024.0037. Epub 2024 Jun 27.
2
Barriers and facilitators to the uptake of the Ischaemia with Non-Obstructive Coronary Arteries (INOCA) recommendation by cardiologists in the Netherlands: A qualitative study.荷兰心脏病专家采纳非阻塞性冠状动脉缺血(INOCA)建议的障碍与促进因素:一项定性研究
Int J Cardiol Cardiovasc Risk Prev. 2025 Jul 29;27:200480. doi: 10.1016/j.ijcrp.2025.200480. eCollection 2025 Dec.
3
Follow-up of patients with myocardial ischemia without obstructive coronary lesions.无阻塞性冠状动脉病变的心肌缺血患者的随访
Arch Peru Cardiol Cir Cardiovasc. 2025 Jun 27;6(2):69-74. doi: 10.47487/apcyccv.v6i2.472. eCollection 2025 Apr-May.
4
Societal, occupational, and economic considerations for women with (M)INOCA: a narrative review.患有(微血管性)无阻塞性冠状动脉疾病的女性的社会、职业和经济考量:一项叙述性综述
Int J Occup Med Environ Health. 2025 Jul 8;38(3):207-221. doi: 10.13075/ijomeh.1896.02527. Epub 2025 Jun 13.
5
Tailored treatment of specific diagnosis improves symptoms and quality of life in patients with myocardial Ischemia and Non-obstructive Coronary Arteries.针对特定诊断的个体化治疗可改善心肌缺血和非阻塞性冠状动脉疾病患者的症状及生活质量。
Sci Rep. 2025 May 30;15(1):18968. doi: 10.1038/s41598-025-02400-5.
6
[Diagnosis and treatment of patients with ANOCA. Consensus document of the SEC-Clinical Cardiology Association/SEC-Interventional Cardiology Association/SEC-Ischemic Heart Disease and Acute Cardiac Care Association/ SEC-Cardiovascular Imaging Association].[无阻塞性冠状动脉疾病患者的诊断与治疗。西班牙心脏病学会-临床心脏病学协会/西班牙心脏病学会-介入心脏病学协会/西班牙心脏病学会-缺血性心脏病与急性心脏护理协会/西班牙心脏病学会-心血管影像协会共识文件]
REC Interv Cardiol. 2023 Dec 20;6(2):106-116. doi: 10.24875/RECIC.M23000422. eCollection 2024 Apr-Jun.
7
More testing, more findings: the evolving story of coronary vascular dysfunction.更多检测,更多发现:冠状动脉血管功能障碍的演变历程
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):11-14. doi: 10.21037/cdt-24-549. Epub 2025 Feb 25.
8
Coronary Microvascular Dysfunction and Vasospastic Angina-Pathophysiology, Diagnosis and Management Strategies.冠状动脉微血管功能障碍与血管痉挛性心绞痛——病理生理学、诊断及管理策略
J Clin Med. 2025 Feb 10;14(4):1128. doi: 10.3390/jcm14041128.
9
Evolution of Coronary Microvascular Dysfunction Prevalence over Time and Across Diagnostic Modalities in Patients with ANOCA: A Systematic Review.无阻塞性冠状动脉疾病(ANOCA)患者冠状动脉微血管功能障碍患病率随时间及不同诊断方式的演变:一项系统评价
J Clin Med. 2025 Jan 27;14(3):829. doi: 10.3390/jcm14030829.
10
Coronary Microvascular Dysfunction: Insights on Prognosis and Future Perspectives.冠状动脉微血管功能障碍:对预后的见解及未来展望
Rev Cardiovasc Med. 2025 Jan 20;26(1):25757. doi: 10.31083/RCM25757. eCollection 2025 Jan.

本文引用的文献

1
Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity.有冠状动脉微血管功能障碍但无阻塞性冠状动脉疾病的女性运动能力降低。
Int J Cardiol. 2019 Oct 15;293:1-9. doi: 10.1016/j.ijcard.2019.07.048. Epub 2019 Jul 17.
2
Ischemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?缺血性无阻塞性冠状动脉疾病(INOCA):风险是什么?
J Am Heart Assoc. 2018 Sep 4;7(17):e008868. doi: 10.1161/JAHA.118.008868.
3
Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.肥胖患者的冠状动脉微血管功能障碍与心血管风险
J Am Coll Cardiol. 2018 Aug 14;72(7):707-717. doi: 10.1016/j.jacc.2018.05.049.
4
Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease.定量心血管磁共振灌注成像是识别微血管性冠状动脉疾病中血流储备减少的方法。
J Cardiovasc Magn Reson. 2018 Feb 22;20(1):14. doi: 10.1186/s12968-018-0435-1.
5
Role of Stress Cardiac Magnetic Resonance Imaging in Women with Suspected Ischemia but No Obstructive Coronary Artery Disease.应激心脏磁共振成像在疑似心肌缺血但无阻塞性冠状动脉疾病女性中的作用
J Radiol Nurs. 2017 Sep;36(3):180-183. doi: 10.1016/j.jradnu.2017.04.016. Epub 2017 Aug 30.
6
Fully quantitative cardiovascular magnetic resonance myocardial perfusion ready for clinical use: a comparison between cardiovascular magnetic resonance imaging and positron emission tomography.全面定量心血管磁共振心肌灌注成像准备临床应用:心血管磁共振成像与正电子发射断层扫描比较。
J Cardiovasc Magn Reson. 2017 Oct 19;19(1):78. doi: 10.1186/s12968-017-0388-9.
7
International standardization of diagnostic criteria for microvascular angina.微血管性心绞痛诊断标准的国际化。
Int J Cardiol. 2018 Jan 1;250:16-20. doi: 10.1016/j.ijcard.2017.08.068. Epub 2017 Sep 8.
8
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程
Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
9
Validity and Reliability of the 8-Item Work Limitations Questionnaire.八条目工作限制问卷的有效性和可靠性。
J Occup Rehabil. 2017 Dec;27(4):576-583. doi: 10.1007/s10926-016-9687-5.
10
Productivity losses associated with cardiovascular disease: a systematic review.与心血管疾病相关的生产力损失:一项系统综述。
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):759-769. doi: 10.1080/14737167.2016.1259571. Epub 2016 Nov 21.